J&J, SI-BONE, Medtronic & more: 10 key notes

Written by Anuja Vaidya | August 26, 2016 | Print  | Email

Here are 10 key notes on orthopedic and spine device companies over the past week.

Johnson & Johnson could beat out Apple and Google's parent company Alphabet as the first $1 trillion company.


Medtronic reported $7.1 billion in worldwide revenue, in first quarter revenue for the 2017 fiscal year, which ended July 29, 2016.


Gregory T. Lucier is propelling NuVasive into a new wave of spine dominance.


Hewatt McGraw Sims, MD, of Coffee Regional Medical Center in Douglas, Ga., collaborated with Amendia to develop the Syzygy Stabilization System for spondylolisthesis patients.


Researchers published the two-year results from SI-BONE's INSITE study comparing the iFuse Implant System to non-surgical management for sacroiliac joint dysfunction.


The fifth patient implanted with InVivo Therapeutics' Neuro-Spinal Scaffold in the INSPIRE study improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury.


CTL Medical entered a General Services Administration partnership with Firehouse Medical, under which CTL Medical will sell its spinal implants and devices to the U.S. government.


TranS1 was recently celebrated as Colorado's "Most Innovative Workplace."


India-based Apollo Hospitals Hyderabad's surgeons performed eight spine surgeries using Mazor Robotics' technology.


Oral-maxillofacial surgeons attending the Taiwan Association of Maxillofacial Surgeons Forum on Contemporary Facial Skeletal Surgery seemed intrigued by Misonix's BoneScalpel.


More articles on devices:
SI-BONE's iFuse continues to gain steam — 6 observations from trial yielding 2-year results
Medtronic, Stryker among top spinal fixation market players— 3 things to note
Medical device fees to FDA will be nearly $1B, but review process to improve: 5 key notes


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.